A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
- Resource Type
- Article
- Authors
- Amengual, Jennifer E.; Lichtenstein, Renee; Lue, Jennifer; Sawas, Ahmed; Deng, Changchun; Lichtenstein, Emily; Khan, Karen; Atkins, Laine; Rada, Aishling; Kim, Hye A.; Chiuzan, Codruta; Kalac, Matko; Marchi, Enrica; Falchi, Lorenzo; Francescone, Mark A.; Schwartz, Lawrence; Cremers, Serge; O'Connor, Owen A.
- Source
- In Blood 25 January 2018 131(4):397-407
- Subject
- Language
- ISSN
- 0006-4971